Peregrine Capital Management LLC Spring Works Therapeutics, Inc. Transaction History
Peregrine Capital Management LLC
- $3.18 Billion
- Q4 2024
A detailed history of Peregrine Capital Management LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 161,186 shares of SWTX stock, worth $7.9 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
161,186
Previous 165,534
2.63%
Holding current value
$7.9 Million
Previous $5.3 Million
9.81%
% of portfolio
0.18%
Previous 0.17%
Shares
9 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$351 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$276 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$170 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$161 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$147 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.06B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...